DoMore Diagnostics alternatives and competitors
The closest alternatives to DoMore Diagnostics are Valar Labs, ArteraAI, Stratipath and Proscia.
Histotype Px Colorectal predicts recurrence and survival in stage II and III colorectal cancer from standard H and E stained slides, placing patients in low, intermediate or high risk groups to inform whether adjuvant chemotherapy should follow surgery.
10 alternatives to DoMore Diagnostics
What each product does, with its price as the vendor publishes it.
-
V
Valar Labs is a precision oncology company, founded in 2021, whose tests predict treatment response and prognosis from routine H and E slides using its Computational Histology AI platform, trained on more than 500,000 pathologist annotations.
-
A
ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. It is unrelated to Artera of Santa Barbara (artera.io), which makes patient communication agents.
-
S
Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe.
Price: No published price
-
P
Proscia sells Concentriq, a digital pathology platform that clinical laboratories and life sciences organizations use to manage, view and analyze whole slide images.
Price: No published price
-
A
Aiosyn sells AI that analyzes images of stained tissue, to pathology laboratories and to drug companies running animal studies.
Price: No published price
-
P
Cleo Breast and Cleo Skin are AI tools for clinical pathology laboratories in Europe that detect and quantify cancer features in whole slide images.
Price: No published price
-
P
PreciseDx sells PreciseBreast, a test that predicts whether early breast cancer will come back, using AI to read the cell patterns on a routine stained slide.
Price: No published price
-
P
PathAI sells AISight, a cloud image management system that anatomic pathology laboratories use to manage cases, read slides on screen and run AI, along with its own algorithms and a menu of partner algorithms.
Price: No published price
-
A
Aiforia sells cloud based deep learning image analysis that pathology laboratories use for cancer diagnostics and that researchers use for preclinical work.
Price: No published price
-
M
Mindpeak sells AI that scores cancer biomarkers on pathology slides, which laboratories use to quantify HER2, ER, PR, Ki-67 and PD-L1 on immunohistochemistry and H&E images.
Price: No published price
DoMore Diagnostics alternatives, answered
What are the best alternatives to DoMore Diagnostics?
The closest alternatives to DoMore Diagnostics are Valar Labs, ArteraAI, Stratipath, Proscia and Aiosyn. Valar Labs is a precision oncology company, founded in 2021, whose tests predict treatment response and prognosis from routine H and E slides using its Computational Histology AI platform, trained on more than 500,000 pathologist annotations. ArteraAI is the Los Altos, California company at artera.ai that builds multimodal AI cancer tests. Stratipath Breast assigns early stage invasive breast cancers to low or high risk groups from routine H&E slides, as a faster, cheaper alternative to gene expression tests for pathology laboratories and breast cancer teams in Europe.
Who are DoMore Diagnostics's competitors?
DoMore Diagnostics's competitors in the Digital Pathology AI category include Valar Labs, ArteraAI, Stratipath, Proscia, Aiosyn and Primaa.